Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Control of medical comorbidities in individuals with HIV.

Monroe AK, Chander G, Moore RD.

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):458-62. doi: 10.1097/QAI.0b013e31823801c4.

2.

Predictors of glycaemic control among HIV-positive veterans with diabetes.

Davies ML, Johnson MD, Brown JN, Bryan WE, Townsend ML.

Int J STD AIDS. 2015 Mar;26(4):262-7. doi: 10.1177/0956462414535207. Epub 2014 May 14.

PMID:
24828555
3.

Comorbidity-related treatment outcomes among HIV-infected adults in the Bronx, NY.

Chu C, Umanski G, Blank A, Meissner P, Grossberg R, Selwyn PA.

J Urban Health. 2011 Jun;88(3):507-16. doi: 10.1007/s11524-010-9540-7.

4.

Predictors of dual control of HIV and diabetes.

Zuniga J, Nguyen ML, Holstad M.

AIDS Care. 2016 Sep;28(9):1124-7. doi: 10.1080/09540121.2016.1139667. Epub 2016 Feb 12.

PMID:
26872692
5.

Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy.

Hanna DB, Jung M, Xue X, Anastos K, Cocohoba JM, Cohen MH, Golub ET, Hessol NA, Levine AM, Wilson TE, Young MA, Kaplan RC.

AIDS Patient Care STDS. 2016 Oct;30(10):445-454.

PMID:
27749112
6.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
7.
8.

Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.

Baekken M, Os I, Sandvik L, Oektedalen O.

J Hypertens. 2008 Nov;26(11):2126-33. doi: 10.1097/HJH.0b013e32830ef5fb.

PMID:
18854751
9.

HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

So-Armah KA, Chang J, Alcorn C, Lo Re V, Baker JV, Tracy R, Butt AA, Agan BK, Rimland D, Gibert CL, Goetz MB, Oursler KK, Rodriguez-Barradas MC, Kuller LH, Brown ST, Stein JH, Skanderson M, Justice AC, Freiberg MS.

Curr HIV Res. 2014;12(1):50-9.

10.

Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.

Gardner LI, Klein RS, Szczech LA, Phelps RM, Tashima K, Rompalo AM, Schuman P, Sadek RF, Tong TC, Greenberg A, Holmberg SD; HIV Epidemiology Research Study Group.

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):320-30.

PMID:
14600579
11.

Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.

Galán RJ, Cidoncha EC, Martin MF, Rodriguez CC, Almeida CV, Verdugo RM.

J Manag Care Pharm. 2013 Jul-Aug;19(6):448-53.

12.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
13.

Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.

Lucas GM, Chaisson RE, Moore RD.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):321-8.

PMID:
12843742
14.

Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.

Duro M, Rebelo I, Barreira S, Sarmento-Castro R, Medeiros R, Almeida C.

Int J STD AIDS. 2015 Oct;26(11):796-802. doi: 10.1177/0956462414554814. Epub 2014 Oct 2.

PMID:
25281540
15.

Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.

Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R.

J Manag Care Spec Pharm. 2014 Aug;20(8):844-50.

16.
17.

HIV infection and glycemic response to newly initiated diabetic medical therapy.

Han JH, Crane HM, Bellamy SL, Frank I, Cardillo S, Bisson GP; Centers for AIDS Research Network of Integrated Clinical Systems (CNICS).

AIDS. 2012 Oct 23;26(16):2087-95. doi: 10.1097/QAD.0b013e328359a8e5.

18.

Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011.

Martin DA, Luz PM, Lake JE, Clark JL, Veloso VG, Moreira RI, Cardoso SW, Klausner JD, Grinsztejn B.

BMC Infect Dis. 2014 Jun 11;14:322. doi: 10.1186/1471-2334-14-322.

19.

Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.

Keiser P, Nassar N, White C, Koen G, Moreno S.

HIV Clin Trials. 2002 Jul-Aug;3(4):296-303.

PMID:
12187503
20.

Premature age-related comorbidities among HIV-infected persons compared with the general population.

Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F.

Clin Infect Dis. 2011 Dec;53(11):1120-6. doi: 10.1093/cid/cir627. Epub 2011 Oct 13.

PMID:
21998278

Supplemental Content

Support Center